328 related articles for article (PubMed ID: 28754552)
1. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
[TBL] [Abstract][Full Text] [Related]
2. UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation.
Lohmann F; Sachs M; Meyer TN; Sievert H; Lindenmeyer MT; Wiech T; Cohen CD; Balabanov S; Stahl RA; Meyer-Schwesinger C
Biochim Biophys Acta; 2014 Jul; 1842(7):945-58. PubMed ID: 24583340
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy.
Meyer-Schwesinger C; Meyer TN; Sievert H; Hoxha E; Sachs M; Klupp EM; Münster S; Balabanov S; Carrier L; Helmchen U; Thaiss F; Stahl RA
Am J Pathol; 2011 May; 178(5):2044-57. PubMed ID: 21514420
[TBL] [Abstract][Full Text] [Related]
4. Non-functional ubiquitin C-terminal hydrolase L1 drives podocyte injury through impairing proteasomes in autoimmune glomerulonephritis.
Reichelt J; Sachs W; Frömbling S; Fehlert J; Studencka-Turski M; Betz A; Loreth D; Blume L; Witt S; Pohl S; Brand J; Czesla M; Knop J; Florea BI; Zielinski S; Sachs M; Hoxha E; Hermans-Borgmeyer I; Zahner G; Wiech T; Krüger E; Meyer-Schwesinger C
Nat Commun; 2023 Apr; 14(1):2114. PubMed ID: 37055432
[TBL] [Abstract][Full Text] [Related]
5. NF-κB upregulates ubiquitin C-terminal hydrolase 1 in diseased podocytes in glomerulonephritis.
Zhang H; Mao X; Sun Y; Hu R; Luo W; Zhao Z; Chen Q; Zhang Z
Mol Med Rep; 2015 Aug; 12(2):2893-901. PubMed ID: 25976522
[TBL] [Abstract][Full Text] [Related]
6. A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies.
Meyer-Schwesinger C; Meyer TN; Münster S; Klug P; Saleem M; Helmchen U; Stahl RA
J Pathol; 2009 Feb; 217(3):452-64. PubMed ID: 18985619
[TBL] [Abstract][Full Text] [Related]
7. UCH-L1 expression of podocytes in diseased glomeruli and in vitro.
Liu Y; Wu J; Wu H; Wang T; Gan H; Zhang X; Liu Y; Li R; Zhao Z; Chen Q; Guo M; Zhang Z
J Pathol; 2009 Apr; 217(5):642-53. PubMed ID: 19214988
[TBL] [Abstract][Full Text] [Related]
8. Role of A20/TNFAIP3 deficiency in lupus nephritis in MRL/lpr mice.
Sun L; Zou LX; Han YC; Zhu DD; Chen T; Wang J
Clin Exp Nephrol; 2020 Feb; 24(2):107-118. PubMed ID: 31811410
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of Usp14 and Uch-L1 on the ubiquitin proteasome system and synaptic activity.
Walters BJ; Campbell SL; Chen PC; Taylor AP; Schroeder DG; Dobrunz LE; Artavanis-Tsakonas K; Ploegh HL; Wilson JA; Cox GA; Wilson SM
Mol Cell Neurosci; 2008 Dec; 39(4):539-48. PubMed ID: 18771733
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin C-terminal hydrolase L1 (UCH-L1) loss causes neurodegeneration by altering protein turnover in the first postnatal weeks.
Reinicke AT; Laban K; Sachs M; Kraus V; Walden M; Damme M; Sachs W; Reichelt J; Schweizer M; Janiesch PC; Duncan KE; Saftig P; Rinschen MM; Morellini F; Meyer-Schwesinger C
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7963-7972. PubMed ID: 30923110
[TBL] [Abstract][Full Text] [Related]
11. The regulation of the UCH-L1 gene by transcription factor NF-κB in podocytes.
Zhang H; Sun Y; Hu R; Luo W; Mao X; Zhao Z; Chen Q; Zhang Z
Cell Signal; 2013 Jul; 25(7):1574-85. PubMed ID: 23567262
[TBL] [Abstract][Full Text] [Related]
12. Podocyte-specific deletion of ubiquitin carboxyl-terminal hydrolase L1 causes podocyte injury by inducing endoplasmic reticulum stress.
Hu Y; Qi C; Shi J; Tan W; Adiljan Abdurusul ; Zhao Z; Xu Y; Wu H; Zhang Z
Cell Mol Life Sci; 2023 Mar; 80(4):106. PubMed ID: 36952018
[TBL] [Abstract][Full Text] [Related]
13. UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis?
Cui JH; Xie X
Inflammation; 2017 Apr; 40(2):657-665. PubMed ID: 28116572
[TBL] [Abstract][Full Text] [Related]
14. UCH-L1 Inhibition Suppresses tau Aggresome Formation during Proteasomal Impairment.
Yu Q; Zhang H; Li Y; Liu C; Wang S; Liao X
Mol Neurobiol; 2018 May; 55(5):3812-3821. PubMed ID: 28540657
[TBL] [Abstract][Full Text] [Related]
15. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders.
Gong B; Leznik E
Drug News Perspect; 2007; 20(6):365-70. PubMed ID: 17925890
[TBL] [Abstract][Full Text] [Related]
16. Plakoglobin is involved in cytoskeletal rearrangement of podocytes under the regulation of UCH-L1.
Fang Y; Li F; Qi C; Mao X; Xu Y; Zhao Z; Wu H; Zhang Z
Biochem Biophys Res Commun; 2020 Aug; 529(1):112-118. PubMed ID: 32560811
[TBL] [Abstract][Full Text] [Related]
17. Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.
McKeon JE; Sha D; Li L; Chin LS
Cell Mol Life Sci; 2015 May; 72(9):1811-24. PubMed ID: 25403879
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin C-terminal hydrolase-L1 potentiates cancer chemosensitivity by stabilizing NOXA.
Brinkmann K; Zigrino P; Witt A; Schell M; Ackermann L; Broxtermann P; Schüll S; Andree M; Coutelle O; Yazdanpanah B; Seeger JM; Klubertz D; Drebber U; Hacker UT; Krönke M; Mauch C; Hoppe T; Kashkar H
Cell Rep; 2013 Mar; 3(3):881-91. PubMed ID: 23499448
[TBL] [Abstract][Full Text] [Related]
19. β-cell dysfunctional ERAD/ubiquitin/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency.
Costes S; Huang CJ; Gurlo T; Daval M; Matveyenko AV; Rizza RA; Butler AE; Butler PC
Diabetes; 2011 Jan; 60(1):227-38. PubMed ID: 20980462
[TBL] [Abstract][Full Text] [Related]
20. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
